Final Program

SUNDAY • MAY 15 65
P221
P222
P223
P224
P225
Facilitator:
P226
P227
P228
P229
P230
P231
P232
P233
Feasibility of Using Smartwatches and Smartphones to
Monitor Patients with COPD/R. Wu, E. De Lara, D. Liaqat, I.
Thukral, A.S. Gershon, Toronto, Canada, p.A1695
Developing a Simple Screening Tool for Detecting COPD in
Primary Care Setting: The PUMA Study/M. Montes De Oca, M.V.
Lopez Varela, A. Rey, A. Casas Herrera, R. Stirvulov, V. Di Boscio,
Caracas, Venezuela, p.A1696
Factors Associated with COPD Underdiagnosis in a High-Risk
Primary Care Population: The PUMA Study/A. Casas Herrera, J.
Jardim, M. Montes De Oca, M.V. Lopez Varela, E. Schiavi, C.
Aguirre, Bogota, Colombia, p.A1697
Therapeutic Choices for COPD Following the Revised GOLD
Guidelines/B.B. Aarli, B.K. Nore, K.Y. Garatun-Tjeldstoe, Bergen,
Norway, p.A1698
Respiratory Medication Use in Primary Care of Four Latin
American Countries: The PUMA study/J. Jardim, R. Stirvulov, D.
Moreno, G. Zabert, M.V. Lopez Varela, M. Montes De Oca, Sao
Pablo, Brazil, p.A1699
W.A. Quezada, MD, New York, NY
The Clinical Impact of an Integrated Care Model for COPD:
Results from the Velletri-Lariano (VELA) Cohort/G. De Filippi,
M. Lallini, G. De Riggi, G. Marchetti, C. Dimartino, A.M. Russetti, E.
Ferrari, R. Pistellli, M.S. Magnoni, M. Riparbelli, A. Rizzi, P.
Angeletti, Velletri, Italy, p.A1700
Risk Factors and a Model Predictive of AECOPD in Patients
Rehospitalized Within 3 Months/Y. Zhou, W. Li, D.Y. Feng, H.L.
Yang, C.T. Liu, T.T. Zhang, Guang Zhou, China, p.A1701
New Diagnosis of COPD with Spirometry Associated with
Reduction in First All-Cause Hospitalization/T.T. Yamanaka, S.
Adimadhyam, T. Lee, M. Joo, Chicago, IL, p.A1702
Absence of Wheezing Is Associated with Underdiagnosis of
Chronic Obstructive Pulmonary Disease: Analysis of the
NHANES, 2007-2012/T. Goto, C.A. Camargo, K. Hasegawa,
Boston, MA, p.A1703
How Accurate Is the Clinical Diagnosis of COPD in
Hospitalized Patients?/M. Hanna, F.D. Ponce, Z. Ghazarian, R.
Sekhon, M. Lange, M. Ismail, M.A. Khan, Paterson, NJ, p.A1704
Accuracy of Self-Reporting in Diagnosis of COPD/N.P.
Kozodoy, E.C. Crawford, J. Hammersley, J.C. Willey, Toledo, OH,
p.A1705
Assessment of COPD Severity in a Real-Life Cohort of German
Patients- 1-Year Follow-Up Data from the DACCORD Study/H.
Worth, R. Buhl, C.-P. Criee, P. Kardos, N. Lossi, C. Mailaender, C.
Vogelmeier, Fuerth, Germany, p.A1706
A Brief Mindfulness Program to Increase Quality of Life in
Chronic Lung Disease/R. Benzo, J.L. Kirsch, J. Hoult, D.
Rasmussen, Rochester, MN, p.A1707
A50
THEMATIC POSTER SESSION
ASTHMA: OBSERVATIONAL STUDIES
9:00 a.m. - 4:15 p.m. MOSCONE CENTER
Viewing: Posters will be on display for entire session.
Area A, Hall D (North Building, Lower Level)
Discussion: 11:00-11:45: authors will be present for individual discussion
11:45-12:45: authors will be present for discussion with assigned facilitators
Facilitator:
P82
P83
P84
P85
P86
P87
P88
P89
P90
A. Sood, MD, MPH, Albuquerque, NM
Physician Perspectives on the Burden and Management of
Asthma in Six Countries: The Global Asthma Physician Survey
(GAPS)/D. Hinds, K.R. Chapman, P. Piazza, M. Gibbs, C. Raherison,
K. Gaalswyk, T. Greulich, J. Lin, K. Davis, Collegeville, PA, p.A1708
Obesity Predisposes to Airway Closure During Bronchial
Challenge in Asthma/M. Subramanian, D.G. Chapman, D.A.
Kaminsky, C.G. Irvin, L.J. Smith, J.H.T. Bates, A.E. Dixon,
Burlington, VT, p.A1709
Establishing a Correct Diagnosis in Adults Who Have Been
Mis-Diagnosed with Asthma/H. Pham, K. Vandemheen, L.-P. Boulet,
J.M. FitzGerald, M. Ainslie, S. Gupta, C. Lemiere, S. Field, A. McIvor,
P. Hernandez, I. Mayers, S.D. Aaron, Ottawa, Canada, p.A1710
Trends in Healthcare Utilization for Asthma Exacerbations
Among Diverse US Populations and Geographic Regions:
2004-2010/E.K. Larkin, T. Gebretsadik, T. Hartert, R.L. Lee, A.M.
Evans, N.M. Sicignano, A.C. Wu, C. Iribarren, M. Butler, E. Mitchell,
J. Morrow, C. Stone, K. Turi, P. Wu, Nashville, TN, p.A1711
Risk Factors Of Severe Asthma Exacerbations: A Real World
Study/K. Verhamme, M. Engelkes, M. De Ridder, E. Svensson, K.
Berencsi, D. Prieto-Alhambra, C. Giaquinto, F. Lapi, G. Picelli, N.
Boudiaf, F.C. Albers, S. Cockle, E. Bradford, R. Suruki, P.
Rijnbeek, M. Sturkenboom, Rotterdam, Netherlands, p.A1712
Predictors of Added Value of Exhaled Nitric Oxide (FeNO) in
the Management of Asthma: Insight from Medical Practice/I.
Coman, Y. Dubois, C. Bergeron, Montreal, Canada, p.A1713
Feedback on Adherence and Inhaler Technique Using the INCA
Device: A Randomised Control Trial in Severe Asthma/I.
Sulaiman, E. MacHale, J. Seheult, S. D’Arcy, V. Rapcan, M.
Mokoka, B. Cushen, I. Killane, A. Franciosi, A. Sahadevan, M.
Keane, J.M. Keane, S. Lane, D. Murphy, R. Reilly, R. Costello,
Dublin, Ireland, p.A1714
Inhaler Technique Errors Have an Impact on Drug Delivery./I.
Sulaiman, J. Seheult, N. Sadasivuni, B. Cushen, M. Mokoka, R.
Costello, Dublin, Ireland, p.A1715
Does Personality Traits and Medication Adherence Affect
Control of Asthma?/A.F. Kalpaklioglu, A. Baccioglu, A.
Yorgancioglu, Y. Havlucu, B. Gemicioglu, S. Sheikh, M. Erdinc, O.
Goksel, Kirikkale, Turkey, p.A1716
SUNDAY MORNING
ATS 2016 • San Francisco